Routes ofadministration Topical Legal status Investigational PubChem CID 159603 Molar mass 314.382 g/mol Pubchem 159603 ChemSpider ID 140330 | ATC code none CAS Number 144875-48-9 IUPHAR/BPS 5051 Route Topical medication ChEMBL ID 383322 IUPHAR/BP 5051 | |
 | ||
2016 clinical research forum top 10 resiquimod therapy of cutaneous t cell lymphoma
Resiquimod (R-848) is a drug that acts as an immune response modifier, and has antiviral and antitumour activity. It is used as a topical gel in the treatment of skin lesions such as those caused by the herpes simplex virus and cutaneous T cell lymphoma, and as an adjuvant to increase the effectiveness of vaccines. It has several mechanisms of action, being both an agonist for toll-like receptor 7 and 8, and an upregulator of the opioid growth factor receptor.
Contents
- 2016 clinical research forum top 10 resiquimod therapy of cutaneous t cell lymphoma
- What does resiquimod mean
- References
What does resiquimod mean
References
Resiquimod Wikipedia(Text) CC BY-SA